Last $1.42 USD
Change Today +0.02 / 1.43%
Volume 7.4K
PRPH On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ted William Karkus

Chairman and Chief Executive Officer, ProPhase Labs, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 1 different industries.

See Board Relationships
55$958,121
As of Fiscal Year 2013

Background*

Mr. Ted William Karkus founded 2001 Forrester Financial LLC and serves as its Managing Member. Mr. Karkus has been the Chief Executive Officer of ProPhase Labs, Inc. since June 2009. He is a Management Consultant at Forrester. He has extensive relationships with investment bankers, the media and a network of institutional investors and high net worth individuals. Mr. Karkus was instrumental in assisting the turn around of ID Biomedical, an influenza vaccine manufacturer, ...

Read Full Background

Corporate Headquarters*

621 North Shady Retreat Road
Doylestown, Pennsylvania 18901

United States

Phone: 215-345-0919
Fax: --

Board Members Memberships*

2009-Present
Chairman and Chief Executive Officer

Education*

MBA 1984
Columbia Business School
Unknown/Other Education 1981
Tufts University

Other Affiliations*

Annual Compensation*

Salary$675,000
Bonus$100,000
Total Annual Compensation$775,000

Stock Options*

Restricted Stock Awards$82,500
All Other Compensation$45,483
Exercisable Options300,000
Total Number of Options700,000

Total Compensation*

Total Annual Cash Compensation$820,483
Total Short Term Compensation$775,000
Other Long Term Compensation$127,983
Total Calculated Compensation$958,121
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRPH:US $1.42 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Jeffrey M. Yordon Founder, Chairman and Chief Executive Officer
Sagent Pharmaceuticals, Inc.
$615.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROPHASE LABS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.